Hiroaki Iwamoto

2.6k total citations
124 papers, 1.9k citations indexed

About

Hiroaki Iwamoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroaki Iwamoto has authored 124 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 27 papers in Surgery. Recurrent topics in Hiroaki Iwamoto's work include Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Hiroaki Iwamoto is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Hiroaki Iwamoto collaborates with scholars based in Japan, United States and Taiwan. Hiroaki Iwamoto's co-authors include Atsushi Mizokami, Kouji Izumi, Munechika Enjoji, Rie Sugimoto, Yoshifumi Kadono, Makoto Nakamuta, Hajime Nawata, Seiya Tada, Suguru Kadomoto and Kazuyoshi Shigehara and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.

In The Last Decade

Hiroaki Iwamoto

115 papers receiving 1.9k citations

Peers

Hiroaki Iwamoto

PRM

ONCOL

HEPAT

EPIDE

Hideki Sakai Japan

Bin Sun China

Norihiko Sakai Japan

Zhijun Wang China

Shinichi Ota Japan

Fredrik Rorsman Sweden

Hiroyuki Matsuda Japan

Yasuhiro Ogawa Japan

Yan Huang China

Guoyue Lv China

Hideki Sakai Japan

Hiroaki Iwamoto

993 ×2.0

PRM

290 ×0.6

ONCOL

474 ×1.0

216 ×0.6

HEPAT

346 ×1.0

EPIDE

Citations per year, relative to Hiroaki Iwamoto Hiroaki Iwamoto (= 1×) peers Hideki Sakai

Countries citing papers authored by Hiroaki Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Iwamoto more than expected).

Fields of papers citing papers by Hiroaki Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Iwamoto. The network helps show where Hiroaki Iwamoto may publish in the future.

Co-authorship network of co-authors of Hiroaki Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Iwamoto. A scholar is included among the top collaborators of Hiroaki Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Iwamoto. Hiroaki Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sakurai, Takayuki, Shigeyuki Takamatsu, Hiroshi Kano, et al.. (2025). Biochemical response to neoadjuvant hormonal therapy predicts long-term prostate cancer survival outcomes after high-dose-rate brachytherapy with external beam radiotherapy. Scientific Reports. 15(1). 5118–5118.

Nohara, Takahiro, Tetsuya Kawahara, Hiroshi Kano, et al.. (2025). Association Between Preoperative 5‐Aminolevulinic Acid Administration Timing and Perioperative Hypotension. International Journal of Urology. 32(12). 1827–1833. 1 indexed citations

Izumi, Kouji, Hiroshi Kano, Tomoyuki Makino, et al.. (2025). Comparison of the efficacy of enfortumab vedotin and paclitaxel plus carboplatin in patients with metastatic urothelial carcinoma. International Journal of Clinical Oncology. 30(3). 524–531.

Hori, Tomohiro, Hiroaki Iwamoto, Tomoyuki Makino, et al.. (2025). Comprehensive Genome Profiling Test in Japanese Patients With Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study. Cureus. 17(1). e77300–e77300.

Izumi, Kouji, Hiroshi Kano, Tomoyuki Makino, et al.. (2024). Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis. Neoplasia. 60. 101103–101103. 4 indexed citations

Nohara, Takahiro, Hiroshi Kano, Renato Naito, et al.. (2024). Comprehensive analysis of perioperative hypotension in photodynamic diagnosis‐assisted transurethral resection of bladder tumor with 5‐aminolevulinic acid. International Journal of Urology. 31(8). 891–898. 5 indexed citations

Iwamoto, Hiroaki, Tomohiro Hori, Hiroshi Kano, et al.. (2024). Novel Treatment Strategies for Low-Risk Metastatic Castration-Sensitive Prostate Cancer. Cancers. 16(18). 3198–3198. 2 indexed citations

Makino, Tomoyuki, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, & Atsushi Mizokami. (2023). Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines. 11(6). 1604–1604. 1 indexed citations

Makino, Tomoyuki, Kouji Izumi, Hiroaki Iwamoto, et al.. (2023). Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines. 11(2). 533–533. 9 indexed citations

10.

Naito, Renato, Hiroshi Kano, Suguru Kadomoto, et al.. (2023). Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells. Anticancer Research. 43(6). 2433–2444. 1 indexed citations

11.

Nohara, Takahiro, Suguru Kadomoto, Hiroaki Iwamoto, et al.. (2023). Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival. Photodiagnosis and Photodynamic Therapy. 42. 103574–103574. 4 indexed citations

12.

Iwamoto, Hiroaki, Tomoyuki Makino, Suguru Kadomoto, et al.. (2022). Treatment Outcomes in Neuroendocrine Prostate Cancer. Anticancer Research. 42(4). 2167–2176. 14 indexed citations

13.

Kawaguchi, Shohei, Suguru Kadomoto, Hiroaki Iwamoto, et al.. (2022). Influence of the Coronavirus Disease 2019 Vaccine on Drug Therapy for Urological Cancer. Anticancer Research. 42(4). 2105–2111. 1 indexed citations

14.

Kadono, Yoshifumi, Takahiro Nohara, Shohei Kawaguchi, et al.. (2022). Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy. Scientific Reports. 12(1). 3975–3975. 9 indexed citations

15.

Makino, Tomoyuki, Takayuki Sakurai, Shigeyuki Takamatsu, et al.. (2021). The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study. International Journal of Clinical Oncology. 26(12). 2310–2317. 3 indexed citations

16.

Izumi, Kouji, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.. (2019). Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy. In Vivo. 33(2). 643–647. 1 indexed citations

17.

Izumi, Kouji, Kazuaki Machioka, Takashi Shima, et al.. (2019). Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer. In Vivo. 33(3). 877–880. 3 indexed citations

18.

Nakamuta, Makoto, et al.. (2001). Hepatic Epithelioid Hemangioendothelioma. Journal of Clinical Gastroenterology. 32(5). 431–434. 51 indexed citations

19.

Iwamoto, Hiroaki, Makoto Nakamuta, Seiya Tada, et al.. (2000). A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. Journal of Hepatology. 32(5). 762–770. 89 indexed citations

20.

Iwamoto, Hiroaki, Hironori Sakai, Seiya Tada, Makoto Nakamuta, & Hajime Nawata. (1999). Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion. Journal of Laboratory and Clinical Medicine. 134(1). 83–89. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact